- Home
- LPL vs CORT Comparison
LPL vs CORT Comparison
Compare LPL & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LPL | CORT |
|---|---|---|
| Founded | 1985 | 1998 |
| Country | South Korea | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9B | 3.7B |
| IPO Year | 2004 | 2001 |
Fundamental Metrics
Financial Performance| Metric | LPL | CORT |
|---|---|---|
| Price | $4.52 | $41.92 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 6 |
| Target Price | N/A | ★ $107.20 |
| AVG Volume (30 Days) | ★ 2.2M | 1.9M |
| Earning Date | 05-14-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.82 |
| Revenue | N/A | ★ $761,407,000.00 |
| Revenue This Year | $1.04 | $26.08 |
| Revenue Next Year | $3.00 | $31.04 |
| P/E Ratio | ★ $25.64 | $51.52 |
| Revenue Growth | N/A | ★ 12.79 |
| 52 Week Low | $2.72 | $28.66 |
| 52 Week High | $5.67 | $91.00 |
Technical Indicators
Market Signals| Indicator | LPL | CORT |
|---|---|---|
| Relative Strength Index (RSI) | 60.45 | 61.64 |
| Support Level | $4.16 | $32.95 |
| Resistance Level | $5.07 | $41.92 |
| Average True Range (ATR) | 0.20 | 2.84 |
| MACD | 0.06 | 0.67 |
| Stochastic Oscillator | 94.41 | 51.21 |
Price Performance
Historical ComparisonAbout LPL LG Display Co Ltd AMERICAN DEPOSITORY SHARES
LG Display Co Ltd is a South Korea-based company that is principally engaged in developing, manufacturing, and selling TFT-LCD and OLED display panels. The company's products consist of panels for notebook computers, monitors, televisions, smartphones, tablets, and others. The company conducts direct sales through overseas subsidiaries in several countries, including the United States, Germany, Japan, Taiwan, China, and Singapore. These subsidiaries conduct sales activities and offer technical support to clients. The company generates the majority of its revenue from overseas markets, with the rest from South Korea.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.